Long-term Follow-up Study of BHC001 for TDT — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Long-term Follow-up Study of BHC001 for TDT — Stella

Recruiting

Back to Thalassemia, Beta trials

Trial locations(2 sites)

China

The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army, Nanning, Guangxi

Xiangya Hospital of Central South University, Changsha, Hunan

Key details

Sponsor

Bioray Laboratories

Collaborators

The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army, Xiangya Hospital of Central South University

Enrollment target

~6 participants

Started

December 2022

Primary completion

December 2036

Age range

5 Years – 35 Years

Last updated March 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov